4C0C |
Crystal structure of Trypanosoma cruzi CYP51 bound to the inhibitor (R)-N-(3-(1H-indol-3-yl)-1-oxo-1-(pyridin-4-ylamino)propan-2-yl)-4-(4-(2,4-difluorophenyl)piperazin-1-yl)-2-fluorobenzamide. |
date |
|
authors | Calvet, C.M., Vieira, D.F., Choi, J.Y., Cameron, M.D., Gut, J., Kellar, D., Siqueira-Neto, J.L., McKerrow, J.H., Roush, W.R., Podust, L.M. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.04 |
ligand | GOL, HEM, SO4, WVH
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A |
|
|
|
|
Primary reference | 4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency., Calvet CM, Vieira DF, Choi JY, Kellar D, Cameron MD, Siqueira-Neto JL, Gut J, Johnston JB, Lin L, Khan S, McKerrow JH, Roush WR, Podust LM, J Med Chem. 2014 Aug 19. PMID:25101801 |